SureTrader
Home > Boards > US OTC > Medical - Drugs >

Provectus Biopharmaceuticals Inc. (PVCT)

PVCT RSS Feed
Add PVCT Price Alert      Hide Sticky   Hide Intro
Moderator: Mokyo Toe
Search This Board: 
Last Post: 1/20/2018 4:25:53 PM - Followers: 194 - Board type: Free - Posts Today: 2







Business Description

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer and liver cancer. Provectus investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers. The Company has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. PH-10, its topical investigational drug for dermatology, is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus has completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for psoriasis. In addition, Provectus has begun a Phase 3 trial as a therapy for metastatic melanoma. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. For additional information about Provectus, please visit the Company's website at www.provectusbio.com.

The red synthetic dye Rose Bengal is shown in a bottle at Provectus Pharmaceuticals, Inc.


 


CURRENT PVCT PIPELINE (as of May 23, 2017)

--------------------------------------------------------------

Charts and Technical:

PVCT 6 months chart:
http://stockcharts.com/h-sc/ui?s=PVCT&p=D&yr=0&mn=6&dy=0&id=p03754661229

Technical analysis:
http://www.stockta.com/cgi-bin/analysis.pl?symb=PVCT&num1=7&cobrand=&mode=stock

PVCT News and Analysis:

PVCT News Blog with the latest news and analysis:

http://provectuspharmaceuticalsinc.blogspot.ca/p/news.html 

CONNECTING THE DOTS - CURRENT NEWS PAGE
http://provectuspharmaceuticalsinc.blogspot.ca/p/current-news_22.html

CONNECTING THE DOTS - BLOG PAGE

http://provectuspharmaceuticalsinc.blogspot.ca/


PVCT News at OTC 
http://www.otcmarkets.com/stock/PVCT/news

CLINICAL TRIALS Updates and Info:

FOR PV-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PV-10&Search=Search

FOR PH-10 CLINICAL TRIALS:
https://clinicaltrials.gov/ct2/results?term=PH-10&Search=Search

PVCT insiders transactions:
http://www.secform4.com/insider/showhistory.php?symbol=pvct



For Clinical Trials and Compassionate Use Programs, Investor Information including SEC filing and Corporate Presentations, Press and Media Releases, and Contact information:
http://www.pvct.com/index.html

PVCT on YouTube...
http://www.youtube.com/watch?v=nuYpvcnAq4c

------------------------------------------------------------

Contact Info:

Telephone: (866) 594-5999
info@pvct.com
scott@pvct.com

Mailing Address:

Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

--------------------------------------------------------------

PVCT Share Structure
Market Value:  $18,517,732 a/o May 04, 2017
Authorized Shares:  1,000,000,000  a/o Apr 30, 2017
Outstanding Shares:  370,354,643  a/o Apr 30, 2017
-Restricted:  N/A
-Unrestricted:  N/A
Held at DTC: N/A
Float:  75,807,312  a/o Jun 30, 2016
Par Value:  0.001
Transfer Agent  Broadridge Financial Solutions, Inc.
Shareholders of Record:  972 a/o Mar 31, 2017
Short Selling Data
Short Interest 167,323 (69.16%)
Apr 13, 2017
Significant Failures to Deliver No





Insider Shares:
http://www.nasdaq.com/symbol/pvct/insider-trades

Institutional Ownership:
http://www.nasdaq.com/symbol/pvct/institutional-holdings

--------------------------------------------------------------

10Q Filed May 10, 2017:


https://ih.advfn.com/p.php?pid=nmona&article=74554789

8K Filed June 1, 2017; Board elected, no share increase

http://ih.advfn.com/p.php?pid=nmona&article=74843932&symbol=PVCT

8K filed August 1, 2017; Provectus Biopharmaceuticals, Inc. is entitled to receive total damages of $6,027,652

http://ih.advfn.com/p.php?pid=nmona&article=75359078

8K filed October 18, 2917; Provectus announces results from the Company’s ongoing Phase 1b/2 study of IL PV-10 in combination with KEYTRUDA® (pembrolizumab)

https://www.sec.gov/Archives/edgar/data/315545/000149315217011744/ex99-1.htm
SureTrader
PVCT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#9348  Sticky Note FIRST STUDY OF QUALITY OF LIFE OF PATIENTS bleach_ 12/27/17 04:18:15 PM
#9466   abstract posted on IV. bleach_ 01/20/18 04:25:53 PM
#9465   Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts bleach_ 01/20/18 04:25:01 PM
#9464   Sometimes, I am a little thick... Can you Mokyo Toe 01/19/18 10:28:08 PM
#9463   You had news today Work Harder 01/19/18 07:56:01 PM
#9462   Looking good for a recovery here. Not Mokyo Toe 01/18/18 09:47:29 AM
#9460   Fwiw Work Harder 01/17/18 02:18:36 PM
#9459   Whatever reason, again we will never know, it bombaytonic 01/17/18 11:25:12 AM
#9458   If it were a short as you believe, ASITIS 01/16/18 11:44:10 PM
#9457   It’s possible. It’s more plausible in my mind bombaytonic 01/16/18 10:30:45 PM
#9456   You can doubt all you want. Market makers ASITIS 01/16/18 08:06:01 PM
#9455   Yeah, I think it has less to do bombaytonic 01/16/18 07:41:38 PM
#9454   closed at .071 not .072 bleach_ 01/16/18 05:26:35 PM
#9453   CDEL is fronting for Maxim eom ASITIS 01/16/18 04:39:18 PM
#9452   Nice 98K buy at the ask right at Mokyo Toe 01/16/18 04:02:54 PM
#9451   609K share overhang via CDEL at .071 ask. Mokyo Toe 01/16/18 03:40:33 PM
#9450   If we close green and above .072 today bombaytonic 01/16/18 02:03:18 PM
#9449   Early assessment on the charts show a retrace bombaytonic 01/16/18 02:02:09 PM
#9448   I keep asking you to explain your assessment Mokyo Toe 01/16/18 11:11:56 AM
#9445   This is no company, just a scam pit. Jade007 01/15/18 09:51:26 AM
#9444   If you say so Work Harder 01/12/18 07:56:34 PM
#9443   Ill take a stab and say we will bleach_ 01/12/18 07:27:41 PM
#9442   You are wrong. Any brokerage firm registered with ASITIS 01/12/18 07:27:11 AM
#9441   I think you are right about that, but Mokyo Toe 01/11/18 11:31:51 PM
#9440   I've considered it, and don't rule it out. Mokyo Toe 01/11/18 11:30:27 PM
#9439   "we should know in a month" Work Harder 01/11/18 08:49:40 PM
#9438   Why would they do that Work Harder 01/11/18 08:35:20 PM
#9437   Did u ever consider that Maxim gave their ASITIS 01/11/18 08:07:10 PM
#9436   Well, that blew, but we had to kinda Mokyo Toe 01/11/18 04:15:57 PM
#9435   Normal profit taking and pull back from a bombaytonic 01/11/18 11:37:04 AM
#9434   My theory is simple. The rally has Mokyo Toe 01/10/18 02:35:06 PM
#9433   Any theories on this low volume? BoredMedStudent 01/10/18 01:34:09 PM
#9432   If I understand ur question correctly, no. The ASITIS 01/09/18 08:15:16 AM
#9431   Isn’t it conflict of interest for them to snidely 01/09/18 06:22:05 AM
#9430   Sure. Of course. We will never know - bombaytonic 01/08/18 09:04:20 PM
#9429   What I am saying is that I believe ASITIS 01/08/18 08:57:42 PM
#9428   Let’s be honest - Maxim wants their trading bombaytonic 01/08/18 07:38:24 PM
#9427   Quick question. Is Eric's 2.5mm loan in 1Q bleach_ 01/08/18 06:20:10 PM
#9426   By your post, you seem to indicate that ASITIS 01/08/18 05:27:37 PM
#9425   Yes, very gentle indeed. A distant departure from bombaytonic 01/08/18 04:45:05 PM
#9424   .09 close at last, and we didn't even Mokyo Toe 01/08/18 04:08:12 PM
#9423   We are about to bust out. Getting ready bombaytonic 01/08/18 01:12:53 PM
#9422   Its been a nice few months. RiverWolf 01/08/18 12:15:26 PM
#9421   Well said. snidely 01/07/18 08:50:25 AM
#9420   Incidentally, I would like to reply to this Mokyo Toe 01/06/18 08:23:28 PM
#9419   To my understanding, hedge funds do not have ASITIS 01/06/18 11:25:25 AM
#9418   Not entirely true. Whether it’s sub $5, otc, bombaytonic 01/05/18 08:56:57 PM
#9416   Guys, let's lighten up on the fighting. Mokyo Toe 01/05/18 03:40:32 PM
#9410   How are this guys not in jail? They Jade007 01/05/18 12:51:18 PM
#9409   plenty of Maxim warrants to go around, and bleach_ 01/04/18 06:04:29 PM
#9408   Been in since 2014, glad to see some snidely 01/04/18 04:45:44 PM
PostSubject